Whitbread: life without Costa coffee

The hotel and restaurant company boast solid financial results following its sale of Costa to Coca-Cola in £3.9 billion dea.

Whitbread (LON:WTB) posted a solid set of financial results with revenues up 2.6% to £1.1 billion and profits increasing 2.9% to £286 million in its first half (H1) of the year. But its interim results were overshadowed by the £3.9 billion sale of Costa to Coca-Cola (NYSE:KO) that was announced in late-August.

Whitbread had initially planned to spin-off Costa after yielding to pressure from two prominent hedge funds that wanted to see the unit separated from the Premier Inn hotel chain. The company was apparently making good process with the demerger, only for Coca-Cola to make an offer to good to turn down, with the beverage company paying a hefty premium to acquire the business.

‘The highlight of the first half was the announcement of our agreement for the sale of Costa to The Coca-Cola Company for £3.9 billion, which received the overwhelming approval of our shareholders in October,’ Whitbread CEO Alison Britton said.

Coca-Cola still requires regulatory approval from EU and Chinese regulators before the deal can be finalised. Once the deal is completed, Whitbread plans to return a significant portion of the net cash proceeds from the sale of to its shareholders, the company said.

Following the sale of Costa, Whitbread will be left with its Premier Inn hotel business, which has operations in the UK, Germany and the Middle East. In H1, the hotel business delivered sales growth of 4.8%, but Whitbread admitted that it had seen ‘weakness in consumer demand over the summer’.

With the prospect of life without Costa, Whitbread has grown its UK network to more than 74,000 rooms, with plans to add a further 13,000 in the pipeline, the company said.

‘We are now looking forward to dedicating our focus to the significant structural growth opportunities available to Premier Inn in the UK and internationally,’ Britton added.

IGA, may distribute information/research produced by its respective foreign marketing partners within the IG Group of companies pursuant to an arrangement under Regulation 32C of the Financial Advisers Regulations. Where the research is distributed in Singapore to a person who is not an Accredited Investor, Expert Investor or an Institutional Investor, IGA accepts legal responsibility for the contents of the report to such persons only to the extent required by law. Singapore recipients should contact IGA at 6390 5118 for matters arising from, or in connection with the information distributed.

This information/research prepared by IGA or IG Group is intended for general circulation. It does not take into account the specific investment objectives, financial situation or particular needs of any particular person. You should take into account your specific investment objectives, financial situation or particular needs before making a commitment to trade, including seeking advice from an independent financial adviser regarding the suitability of the investment, under a separate engagement, as you deem fit. No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk. In addition to the disclaimer above, the information does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. Any views and opinions expressed may be changed without an update.

See important Research Disclaimer.

Find articles by writer